Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-01-15

Clinical Trial Update: Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

View source ↗

Summary

This update notes that the clinical trial evaluating anecortave acetate for age-related macular degeneration is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anecortave acetate (anecortave acetate)

Snippet

Sponsor: University of Iowa | Conditions: Macular Degeneration | Status: NO_LONGER_AVAILABLE